Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.


Journal

Autoimmunity reviews
ISSN: 1873-0183
Titre abrégé: Autoimmun Rev
Pays: Netherlands
ID NLM: 101128967

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 26 04 2020
accepted: 28 04 2020
pubmed: 8 5 2020
medline: 11 6 2020
entrez: 8 5 2020
Statut: ppublish

Résumé

The coronavirus disease-19 pandemic (COVID-19), which appeared in China in December 2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up extraordinary challenges. This unprecedented situation led to the inception of numerous fundamental research protocols and many clinical trials. It quickly became apparent that although COVID-19, in the vast majority of cases, was a benign disease, it could also develop a severe form with sometimes fatal outcomes. Cytokines are central to the pathophysiology of COVID-19; while some of them are beneficial (type-I interferon, interleukin-7), others appear detrimental (interleukin-1β, -6, and TNF-α) particularly in the context of the so-called cytokine storm. Yet another characteristic of the disease has emerged: concomitant immunodeficiency, notably involving impaired type-I interferon response, and lymphopenia. This review provides an overview of current knowledge on COVID-19 immunopathology. We discuss the defective type-I IFN response, the theoretical role of IL-7 to restore lymphocyte repertoire, as well as we mention the two patterns observed in severe COVID-19 (i.e. interleukin-1β-driven macrophage activation syndrome vs. interleukin-6-driven immune dysregulation). Next, reviewing current evidence drawn from clinical trials, we examine a number of cytokine and anti-cytokine therapies, including interleukin-1, -6, and TNF inhibitors, as well as less targeted therapies, such as corticosteroids, chloroquine, or JAK inhibitors.

Identifiants

pubmed: 32376392
pii: S1568-9972(20)30129-4
doi: 10.1016/j.autrev.2020.102567
pmc: PMC7196557
pii:
doi:

Substances chimiques

Cytokines 0
IL1B protein, human 0
IL6 protein, human 0
Interleukin-1beta 0
Interleukin-6 0
Interferons 9008-11-1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102567

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflict of interest.

Références

Pharm Res. 2002 Oct;19(10):1537-43
pubmed: 12425473
Clin Rev Allergy Immunol. 2018 Jun;54(3):454-479
pubmed: 28578473
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Biochim Biophys Acta. 1985 Jul 31;835(3):448-55
pubmed: 4016141
ACR Open Rheumatol. 2020 May;2(5):283-285
pubmed: 32267072
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
J Infect Dis. 2020 May 11;221(11):1762-1769
pubmed: 32227123
Proc Natl Acad Sci U S A. 1982 Jan;79(1):175-8
pubmed: 6798568
J Med Virol. 2005 Feb;75(2):185-94
pubmed: 15602737
J Immunol. 2010 Apr 1;184(7):3768-79
pubmed: 20200277
Rheumatology (Oxford). 2019 Jan 1;58(1):5-17
pubmed: 29481673
Cell Host Microbe. 2016 Feb 10;19(2):181-93
pubmed: 26867177
Acta Haematol. 2012;128(2):69-72
pubmed: 22678422
BioDrugs. 2019 Feb;33(1):45-60
pubmed: 30560413
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219
pubmed: 32391667
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):411-417
pubmed: 32172546
J Exp Med. 2008 Jul 7;205(7):1701-14
pubmed: 18573906
Front Immunol. 2017 Mar 10;8:259
pubmed: 28344581
Nature. 2006 Mar 9;440(7081):237-41
pubmed: 16407889
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Isr Med Assoc J. 2010 Jul;12(7):443-5
pubmed: 20862830
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3012-7
pubmed: 22315415
J Virol. 2012 Mar;86(6):2900-10
pubmed: 22258243
Blood. 2016 Mar 31;127(13):1666-75
pubmed: 26825707
J Infect Dis. 2015 Dec 15;212(12):1904-13
pubmed: 26198719
J Rheumatol. 2001 Sep;28(9):2120-4
pubmed: 11550985
J Med Virol. 2020 Oct;92(10):1789-1790
pubmed: 32297995
Blood. 2019 Nov 21;134(21):1783-1786
pubmed: 31537529
Lancet. 2020 Feb 29;395(10225):683-684
pubmed: 32122468
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1850-6
pubmed: 8665045
J Infect. 2020 Jul;81(1):e13-e20
pubmed: 32283144
Pediatr Blood Cancer. 2008 Feb;50(2):419-21
pubmed: 16900487
Int J Antimicrob Agents. 2020 May;55(5):105960
pubmed: 32251731
Virology. 2015 Nov;485:330-9
pubmed: 26331680
Annu Rev Immunol. 2009;27:229-65
pubmed: 19302040
PLoS Med. 2006 Sep;3(9):e343
pubmed: 16968120
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Adv Res. 2020 Mar 16;24:91-98
pubmed: 32257431
Front Microbiol. 2019 Jan 29;10:50
pubmed: 30761102
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
J Med Virol. 2020 Jul;92(7):814-818
pubmed: 32253759
Lancet. 2020 May 2;395(10234):1407-1409
pubmed: 32278362
Scand J Immunol. 1997 Apr;45(4):385-92
pubmed: 9105426
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Trials. 2018 Jan 30;19(1):81
pubmed: 29382391
Lupus. 2006;15(5):268-75
pubmed: 16761500
J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2
pubmed: 32360285
J Clin Rheumatol. 2001 Aug;7(4):252-6
pubmed: 17039144
Viruses. 2019 Jan 09;11(1):
pubmed: 30634407
Immunity. 2009 Apr 17;30(4):556-65
pubmed: 19362020
Curr Top Med Chem. 2021;21(10):920-927
pubmed: 33970846
Emerg Microbes Infect. 2020 Dec;9(1):761-770
pubmed: 32228226
ACS Omega. 2018 Dec 31;3(12):18132-18141
pubmed: 30613818
Annu Rev Med. 2015;66:145-59
pubmed: 25386930
Int J Inflam. 2012;2012:156890
pubmed: 22762008
Expert Rev Clin Immunol. 2019 Aug;15(8):813-822
pubmed: 31219357
Blood. 2011 May 12;117(19):5123-32
pubmed: 21436066
Nat Immunol. 2003 Jun;4(6):540-5
pubmed: 12754505
Clin Infect Dis. 2020 Nov 5;71(8):1937-1942
pubmed: 32301997
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Chin Med J (Engl). 2020 May 5;133(9):1132-1134
pubmed: 32149772
Pediatr Rheumatol Online J. 2017 Jan 17;15(1):5
pubmed: 28095869
J Immunol. 2011 Apr 15;186(8):4794-804
pubmed: 21398612
Arthritis Rheum. 2000 Jan;43(1):38-47
pubmed: 10643698
Emerg Infect Dis. 2004 Feb;10(2):317-9
pubmed: 15030704
Chest. 2016 May;149(5):1294-301
pubmed: 26836913
Nature. 2016 Jul 06;535(7610):153-8
pubmed: 27383986
J Infect. 2020 Jun;80(6):656-665
pubmed: 32283155
Nat Rev Immunol. 2013 Dec;13(12):875-87
pubmed: 24157572
Autoimmun Rev. 2020 May;19(5):102524
pubmed: 32220633
Nat Immunol. 2010 Jan;11(1):63-9
pubmed: 19915568
Cell Death Dis. 2018 Sep 5;9(9):904
pubmed: 30185776
Drugs. 2019 Jan;79(1):99-103
pubmed: 30623346
BMC Med. 2013 Aug 22;11:185
pubmed: 23968282
Clin Infect Dis. 2016 May 1;62(9):1178-1185
pubmed: 26908786
Dermatol Ther. 2007 Jul-Aug;20(4):160-74
pubmed: 17970883
J Immunol. 1999 Aug 1;163(3):1521-8
pubmed: 10415055
ACR Open Rheumatol. 2020 May;2(5):276-282
pubmed: 32267081
Hemasphere. 2019 Mar 29;3(2):e191
pubmed: 31723828
Lancet. 2014 Apr 26;383(9927):1503-1516
pubmed: 24290661
Ann Oncol. 2020 Jul;31(7):961-964
pubmed: 32247642
Curr Opin Allergy Clin Immunol. 2011 Dec;11(6):512-6
pubmed: 21971331
BMC Infect Dis. 2020 Dec 21;20(1):963
pubmed: 33349241
Int J Infect Dis. 2014 Mar;20:42-6
pubmed: 24406736
Cell Host Microbe. 2019 May 8;25(5):730-745.e6
pubmed: 31003939
Autoimmun Rev. 2018 Jan;17(1):44-52
pubmed: 29108825
Autoimmun Rev. 2014 Jul;13(7):708-22
pubmed: 24657513
Circ Res. 2000 Sep 1;87(5):E1-9
pubmed: 10969042
Blood. 2005 Oct 1;106(7):2366-74
pubmed: 15860669
J Rheumatol. 2003 Feb;30(2):401-3
pubmed: 12563702
Autoimmun Rev. 2020 May;19(5):102523
pubmed: 32205186
Nat Med. 2006 Nov;12(11):1301-9
pubmed: 17041596
Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7809-14
pubmed: 18490652
Clin Infect Dis. 2020 Apr 15;70(9):1837-1844
pubmed: 31925415
Med Mal Infect. 2020 Jun;50(4):384
pubmed: 32240719
Case Rep Med. 2016;2016:5656320
pubmed: 27688774
Clin Infect Dis. 2022 Sep 05;:
pubmed: 36063397
Rev Med Interne. 2019 Dec;40(12):816-825
pubmed: 31699450
Arthritis Rheum. 1998 Jul;41(7):1258-65
pubmed: 9663484
J Clin Invest. 2020 Apr 1;130(4):1669-1682
pubmed: 31874111
JCI Insight. 2018 Mar 8;3(5):
pubmed: 29515037
Virol J. 2005 Aug 22;2:69
pubmed: 16115318
PLoS Pathog. 2013 Feb;9(2):e1003188
pubmed: 23468627
Medicine (Baltimore). 2014 Mar;93(2):91-99
pubmed: 24646465
Arthritis Rheumatol. 2017 Apr;69(4):854-862
pubmed: 27860460
Cell Death Differ. 2007 Jan;14(1):10-22
pubmed: 16977329
Nat Rev Microbiol. 2009 Jun;7(6):439-50
pubmed: 19430490
Best Pract Res Clin Rheumatol. 2014 Apr;28(2):277-92
pubmed: 24974063
Nat Commun. 2020 Jan 10;11(1):222
pubmed: 31924756
Front Immunol. 2019 Jan 31;10:55
pubmed: 30766533
J Allergy Clin Immunol. 2017 May;139(5):1698-1701
pubmed: 27876626
Nat Rev Immunol. 2015 Apr;15(4):231-42
pubmed: 25790790
J Rheumatol. 1997 Jan;24(1):55-60
pubmed: 9002011
J Biol Chem. 2003 Aug 8;278(32):29752-9
pubmed: 12783879
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134
Sci Rep. 2013;3:1686
pubmed: 23594967
Rheumatol Int. 2021 Jan;41(1):183-188
pubmed: 31324971
J Virol. 2007 Jun;81(12):6346-55
pubmed: 17428862
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Signal Transduct Target Ther. 2020 Feb 21;5(1):18
pubmed: 32296012
Crit Care Med. 2016 Feb;44(2):275-81
pubmed: 26584195
Front Immunol. 2020 May 01;11:827
pubmed: 32425950
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
Autoimmun Rev. 2019 Nov;18(11):102390
pubmed: 31520803
Autoimmun Rev. 2020 Jun;19(6):102537
pubmed: 32251717
Autoimmun Rev. 2020 Jun;19(6):102536
pubmed: 32251718
CPT Pharmacometrics Syst Pharmacol. 2020 Sep;9(9):509-514
pubmed: 32558354
Lancet. 2020 Feb 15;395(10223):473-475
pubmed: 32043983
Cell Mol Immunol. 2020 Aug;17(8):894
pubmed: 32651469
Crit Care Med. 2020 Feb;48(2):e98-e106
pubmed: 31939808
Mol Cell. 2002 Aug;10(2):417-26
pubmed: 12191486
Rheumatology (Oxford). 2019 Nov 1;58(Suppl 6):vi9-vi22
pubmed: 31769856
Immunol Today. 2000 Jun;21(6):254-6
pubmed: 10825735
Front Microbiol. 2019 May 10;10:1057
pubmed: 31134045
J Autoimmun. 2020 Jul;111:102452
pubmed: 32291137
BMJ. 2018 Aug 10;362:k3284
pubmed: 30097460
Cell Biochem Funct. 2016 Jun;34(4):191-6
pubmed: 27001679
Blood. 2012 Dec 6;120(24):4882-91
pubmed: 23012326
Front Immunol. 2019 Feb 01;10:119
pubmed: 30774631
Blood. 2019 Jul 11;134(2):147-159
pubmed: 31015190
Immunol Res. 2015 Feb;61(1-2):53-62
pubmed: 25388963
Antivir Ther. 2004 Dec;9(6):1003-11
pubmed: 15651759
Nat Med. 2005 Aug;11(8):875-9
pubmed: 16007097
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Allergy. 2020 Jul;75(7):1730-1741
pubmed: 32077115
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
FASEB J. 2019 Aug;33(8):8865-8877
pubmed: 31034780
Cell Mol Immunol. 2020 May;17(5):541-543
pubmed: 32203186
Cell Death Discov. 2019 Jun 5;5:101
pubmed: 31231549
J Exp Med. 2005 May 2;201(9):1355-9
pubmed: 15867089
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
J Heart Lung Transplant. 2020 May;39(5):405-407
pubmed: 32362390
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Rev Med Virol. 2020 Nov;30(6):1-9
pubmed: 32845568
Autoimmun Rev. 2015 May;14(5):429-37
pubmed: 25599955
Autoimmun Rev. 2020 Jun;19(6):102538
pubmed: 32268212
Antiviral Res. 2020 Jun;178:104791
pubmed: 32275914
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
BMC Syst Biol. 2016 Sep 23;10(1):93
pubmed: 27663205
Lancet. 2003 May 24;361(9371):1773-8
pubmed: 12781536
J Virol. 2016 Oct 28;90(22):10050-10053
pubmed: 27605675
World J Pediatr. 2020 Jun;16(3):219-221
pubmed: 32026147
Arthritis Rheum. 2006 Oct;54(10):3068-70
pubmed: 17009223
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Cytokine. 2018 Jan;101:14-18
pubmed: 27531077
Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767
pubmed: 29161116
Nat Med. 2018 Jun;24(6):739-748
pubmed: 29808007
Blood. 2006 Nov 15;108(10):3253-61
pubmed: 16868248
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
J Gen Virol. 2013 Dec;94(Pt 12):2679-2690
pubmed: 24077366
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Ann Rheum Dis. 2018 Jun;77(6):840-847
pubmed: 29472362
Nat Rev Immunol. 2020 Sep;20(9):537-551
pubmed: 32203325
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):337-342
pubmed: 32202240
J Virol. 2010 Jan;84(2):1198-205
pubmed: 19864379
Br J Haematol. 2016 Jul;174(2):203-17
pubmed: 27264204
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
Lancet Infect Dis. 2014 Nov;14(11):1090-1095
pubmed: 25278221
Blood. 2018 Mar 29;131(13):1442-1455
pubmed: 29326099

Auteurs

Yvan Jamilloux (Y)

Department of Internal Medicine, Lyon University Hospital, Lyon, France; Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard-Lyon 1, Lyon, France. Electronic address: yvan.jamilloux@chu-lyon.fr.

Thomas Henry (T)

Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard-Lyon 1, Lyon, France.

Alexandre Belot (A)

Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard-Lyon 1, Lyon, France; Department of Pediatric rheumatology, nephrology, and dermatology, Lyon University Hospital, Lyon, France; National Referee Centre for Rheumatic and AutoImmune and Systemic diseases in childrEn (RAISE), Lyon, France.

Sébastien Viel (S)

Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard-Lyon 1, Lyon, France; Service d'Immunologie Biologique, Centre, Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France; National Referee Centre for Rheumatic and AutoImmune and Systemic diseases in childrEn (RAISE), Lyon, France.

Maxime Fauter (M)

Department of Internal Medicine, Lyon University Hospital, Lyon, France; Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard-Lyon 1, Lyon, France.

Thomas El Jammal (T)

Department of Internal Medicine, Lyon University Hospital, Lyon, France.

Thierry Walzer (T)

Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard-Lyon 1, Lyon, France.

Bruno François (B)

Intensive care unit & Inserm CIC 1435 & Inserm UMR 1092, Dupuytren University Hospital, Limoges, France.

Pascal Sève (P)

Department of Internal Medicine, Lyon University Hospital, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH